Role at ANSTO
Terahertz/Far Infrared beamlines assisted investigation into possible composition of lower atmosphere of Saturn's moon Titan.
ANSTO Industry Foundations Scholarship - Priority Focus Area
Insights into the crystallisation process of twin crystals important for drug production.
Physicist and cancer research Dr Mitra Safavi-Naeini, Macromolecular crystallography beamline scientist Dr Eleanor Campbell and Engineering Support Workshop Manager Bianca Shepherd have been chosen by Science and Technology Australia as the next Superstars of STEM
The Australian Synchrotron provides funding support for successful beamtime applicants in the form of travel funding and/or onsite accommodation. Travel funds granted are to be used solely to cover the majority of the cost to travel to the AS facility. The User Office will book accommodation for interstate user groups at the onsite AS Guesthouse.
Choose from our list of research topics and let your students lead a 30 minute Q&A session with our ANSTO experts.
Role at ANSTO
Research represents significant step towards developing vaccine
Senior electronics engineer from SESAME visits following donation of instrumentation to the Middle East's synchrotron in Jordan.
The X-ray Fluorescence Nanoprobe beamline undertakes high-resolution X-ray microspectroscopy, elemental mapping and coherent diffraction imaging – providing a unique facility capable of spectroscopic and full-field imaging. Elemental mapping and XANES studies will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using scanning X-ray diffraction microscopy.
New class of single atoms catalysts for carbon nanotubes characterised.
Resources and a list of user publications associated with Infrared microspectroscopy.
After careful selection, three Australian science teachers are set to fly to Geneva today after winning positions on the International High School Teacher Programme at CERN.
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.